CBD for Brain Tumor Anxiety: What This Trial Found

CBD for brain tumor anxiety is an appealing idea, especially for patients facing heavy emotional and neurologic burdens. This early-terminated randomized crossover trial did not show benefit over placebo for anxiety or depressive symptoms in adults with primary brain tumors. The study is still useful because it helps separate hope, signal, and proof in a vulnerable clinical population.

Read More

Medical Cannabis Counseling for Older Adults: What Physicians Are Telling Patients

Medical cannabis counseling for older adults is becoming more important as more seniors ask clinicians about cannabis for pain, sleep, and anxiety. This study shows that many physicians are having these conversations, but most still do not feel fully prepared to give detailed, age-specific guidance. For patients and providers alike, the message is clear: interest is rising faster than clinical education.

Read More

Metabolic Health Explained

CED Clinical Guide Metabolic Primer General-public explainer Built to clarify metabolism and GLP-1 physiology without flattening the science. Clinical Insight | CED Clinic Metabolism is often discussed in language that is too...

Read More

Semaglutide vs Tirzepatide Comparison: Which Works Better and Why

Semaglutide and tirzepatide are often discussed like cousins in the same family photo, but they are not interchangeable. Tirzepatide currently has the stronger average weight-loss data, while semaglutide keeps several meaningful clinical advantages that still matter quite a bit in real practice. If you are trying to make sense of Wegovy vs Zepbound without getting lost in hype, this is the comparison worth reading.

Read More

Cannabis Telemedicine

Cannabis telemedicine gives patients a practical way to access thoughtful, expert-guided cannabis care from home. This guide explains how cannabis telemedicine works, who benefits most, and why better virtual follow-up can make cannabis care safer, easier, and more personal.

Read More

Adolescent Cannabis and Mental Health in Teens: A Careful Reading of a Large New Study

A large 2026 cohort study found that adolescents reporting cannabis use were more likely to later receive diagnoses of psychotic, bipolar, depressive, and anxiety disorders. This Evidence Watch review explains what the paper actually shows, where the associations are strongest, and why the findings deserve clinical attention. It also makes clear what the study does not prove, especially around causality, product type, and individual risk.

Read More